Jerel Davis

Jerel Davis is a Managing Director at Versant Ventures since June 2011 and has extensive experience in the biotechnology sector, currently involved with companies such as Ventus Therapeutics, Turnstone Biologics, and FireFly Tx. As of January 2020, Jerel serves as Board Chair at Ventus Therapeutics and holds board member positions at multiple companies including Firefly Biologics, Santa Ana Bio, and Tentarix Biotherapeutics, among others. Previously, Jerel was the Lead Board Director at Chinook Therapeutics, Inc. and contributed to RayzeBio. Educational qualifications include a PhD in Population Genetics and Genomics from Stanford University and a BS in Mathematics and Biology from Pepperdine University.